#6.Journal Club. March 2026

An expert review of the paper 'Assessing the efficacy and safety of intradermal injection of different doses of Botulinum Toxin Type A: A randomized, double-blind, placebo-controlled, split-face pilot study in rosacea patients with erythematic telangiectasia'. By Gaynor Hughes aesthetic nurse and BAS Board Member